Australia vs Panama: The number of people with susceptibility test result for rifampicin
Australia
597
in 2021
Panama
497
in 2021
Australia rank
76th
Panama rank
79th
The number of people with susceptibility test result for rifampicin over time
- Australia
- Panama
How they compare
Australia currently reports 597 against 497 in Panama, a difference of 100.
That makes Australia's figure about 1.2 times Panama's.
Across all 5 years both countries report, Australia has been ahead every year.
Australia ranks 76th and Panama ranks 79th of 155 countries.
Australia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Australia | Panama | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 702.67 | 477 | 225.67 | Australia |
| 2020s | 666 | 452.5 | 213.5 | Australia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Australia or Panama?
- Australia, at 597 against 497 in Panama as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Australia and Panama?
- 100, with Australia ahead.
- How many years of comparable data are there for Australia and Panama?
- 5 years are reported by both, from 2017 to 2021.
- How do Australia and Panama rank globally for the number of people with susceptibility test result for rifampicin?
- Australia ranks 76th and Panama ranks 79th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.